IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 136 filers reported holding IMMUNOGEN INC in Q2 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $83,000 | -91.2% | 40,731 | -88.4% | 0.05% | -91.7% |
| Q3 2016 | $942,000 | -13.0% | 351,565 | 0.0% | 0.65% | -18.8% |
| Q2 2016 | $1,083,000 | -24.5% | 351,565 | +108.9% | 0.80% | -24.2% |
| Q1 2016 | $1,434,000 | -37.5% | 168,315 | -0.4% | 1.05% | -37.7% |
| Q4 2015 | $2,293,000 | +43.0% | 168,990 | +1.2% | 1.69% | +32.5% |
| Q3 2015 | $1,603,000 | -32.8% | 167,025 | +0.7% | 1.27% | -25.2% |
| Q2 2015 | $2,386,000 | +59.0% | 165,925 | -1.0% | 1.70% | +57.8% |
| Q1 2015 | $1,501,000 | +124.4% | 167,665 | +52.9% | 1.08% | +128.3% |
| Q4 2014 | $669,000 | -34.7% | 109,635 | +13.4% | 0.47% | -34.7% |
| Q3 2014 | $1,024,000 | +7.2% | 96,700 | +20.1% | 0.72% | +6.3% |
| Q2 2014 | $955,000 | -19.9% | 80,525 | -0.9% | 0.68% | -33.4% |
| Q1 2014 | $1,192,000 | 0.0% | 81,225 | 0.0% | 1.02% | 0.0% |
| Q4 2013 | $1,192,000 | – | 81,225 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
| Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
| Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
| Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
| BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
| SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
| ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |